Dick de Zeeuw

Dick de Zeeuw

UNVERIFIED PROFILE

Are you Dick de Zeeuw?   Register this Author

Register author
Dick de Zeeuw

Dick de Zeeuw

Publications by authors named "Dick de Zeeuw"

Are you Dick de Zeeuw?   Register this Author

100Publications

3448Reads

15Profile Views

Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatin.

Diabetes Obes Metab 2019 Dec 30;21(12):2635-2642. Epub 2019 Sep 30.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13849DOI Listing
December 2019

Renal hyperfiltration defined by high estimated glomerular filtration rate: A risk factor for cardiovascular disease and mortality.

Diabetes Obes Metab 2019 Nov 29;21(11):2368-2383. Epub 2019 Jul 29.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13831DOI Listing
November 2019

Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program.

Diabetes Obes Metab 2019 Nov 14. Epub 2019 Nov 14.

The George Institute for Global Health, UNSW Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13920DOI Listing
November 2019

Proteinuria and cholesterol reduction are independently associated with less renal function decline in statin-treated patients; a post hoc analysis of the PLANET trials.

Nephrol Dial Transplant 2019 Oct;34(10):1699-1706

Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt
Publisher Site
http://dx.doi.org/10.1093/ndt/gfy159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775475PMC
October 2019

Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program.

Diabetologia 2019 Oct 10;62(10):1854-1867. Epub 2019 Aug 10.

The George Institute for Global Health, UNSW Sydney, Level 5, 1 King St, Newtown, Sydney, NSW, 2042, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-019-4955-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731200PMC
October 2019

Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes.

JACC Heart Fail 2019 Oct 23. Epub 2019 Oct 23.

George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia; Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia; Imperial College London, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2019.08.004DOI Listing
October 2019

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

N Engl J Med 2019 06 14;380(24):2295-2306. Epub 2019 Apr 14.

From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) - all in Australia; Imperial College London (B.N.) and the Department of Renal Medicine, UCL Medical School (D.C.W.) - both in London; the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H., D.Z.); the Nephrology Division, NYU School of Medicine and NYU Langone Medical Center, New York (D.M.C.); Baim Institute for Clinical Research (D.M.C., C.P.C., B.M.B.), the Cardiovascular Division (C.P.C.) and the Renal Division and Department of Medicine (B.M.B), Brigham and Women's Hospital, and Harvard Medical School (B.M.B.) - all in Boston; Janssen Research and Development, Raritan, NJ (R.E., S. Bull, G.C., P.-L.C., Y.Y., G.M.); Indiana University School of Medicine and Veterans Affairs Medical Center, Indianapolis (R.A.); the Department of Medicine, University of Chicago Medicine, Chicago (G.B.); the Division of Biostatistics, Department of Population Health Sciences, University of Utah, Salt Lake City (T.G.); the Division of Nephrology, University of British Columbia, Vancouver (A.L.), and the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto (B.Z.) - all in Canada; the Renal Division, Peking University First Hospital, Beijing (H.Z.); and the Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA (K.W.M.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1811744
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1811744DOI Listing
June 2019

How to measure and monitor albuminuria in healthy toddlers?

PLoS One 2018 21;13(6):e0199309. Epub 2018 Jun 21.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199309PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013108PMC
April 2019

Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries.

Diab Vasc Dis Res 2019 01 21;16(1):47-56. Epub 2018 Sep 21.

1 Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1479164118795559DOI Listing
January 2019

Treating diabetic complications; from large randomized clinical trials to precision medicine.

Diabetes Obes Metab 2018 10;20 Suppl 3:3-5

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/dom.13418
Publisher Site
http://dx.doi.org/10.1111/dom.13418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221145PMC
October 2018

A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) - Study Design and Baseline Characteristics.

Kidney Blood Press Res 2018 16;43(1):181-190. Epub 2018 Feb 16.

Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000487500DOI Listing
September 2018

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials.

Lancet Diabetes Endocrinol 2018 09 21;6(9):691-704. Epub 2018 Jun 21.

The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia; Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(18)30141-4DOI Listing
September 2018

Determining the optimal dose of atrasentan by evaluating the exposure-response relationships of albuminuria and bodyweight.

Diabetes Obes Metab 2018 08 1;20(8):2019-2022. Epub 2018 May 1.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/dom.13312
Publisher Site
http://dx.doi.org/10.1111/dom.13312DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055665PMC
August 2018

Baseline characteristics and enrichment results from the SONAR trial.

Diabetes Obes Metab 2018 08 1;20(8):1829-1835. Epub 2018 May 1.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/dom.13315
Publisher Site
http://dx.doi.org/10.1111/dom.13315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055730PMC
August 2018

Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: A primary care cohort study.

Diabetes Obes Metab 2018 06 20;20(6):1377-1383. Epub 2018 Feb 20.

University of Groningen, University Medical Centre Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969103PMC
June 2018

Renal trials in diabetes need a platform: time for a global approach?

Lancet Diabetes Endocrinol 2018 05 7;6(5):356-358. Epub 2017 Aug 7.

George Institute, University of New South Wales, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(17)30263-2DOI Listing
May 2018

Does SGLT2 inhibition with dapagliflozin overcome individual therapy resistance to RAAS inhibition?

Diabetes Obes Metab 2018 01 8;20(1):224-227. Epub 2017 Aug 8.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13057DOI Listing
January 2018

Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy.

Am J Kidney Dis 2018 01 16;71(1):91-101. Epub 2017 Nov 16.

Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2017.08.010DOI Listing
January 2018

The albuminuria-lowering response to dapagliflozin is variable and reproducible among individual patients.

Diabetes Obes Metab 2017 10 8;19(10):1363-1370. Epub 2017 Jun 8.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12936DOI Listing
October 2017

Is Chronic Dialysis the Right Hard Renal End Point To Evaluate Renoprotective Drug Effects?

Clin J Am Soc Nephrol 2017 Oct 18;12(10):1595-1600. Epub 2017 Sep 18.

Department of Clinical Pharmacy and Pharmacology and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.09590916DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628725PMC
October 2017

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

N Engl J Med 2017 08 12;377(7):644-657. Epub 2017 Jun 12.

From the George Institute for Global Health, Faculty of Medicine, UNSW Sydney (B.N., V.P.), the Charles Perkins Centre (B.N.), and the Royal North Shore Hospital (V.P., G.F.), University of Sydney, and the Faculty of Medicine, University of New South Wales (B.N.) - all in Sydney; Imperial College London, London (B.N.), and the Oxford Centre for Diabetes, Endocrinology, and Metabolism and Harris Manchester College, University of Oxford, Oxford (D.R.M.) - both in the United Kingdom; the Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA (K.W.M.); the University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (D.Z.); and Janssen Research and Development, Raritan, NJ (N.E., W.S., G.L., M.D.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1611925
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1611925DOI Listing
August 2017

Variability in response to albuminuria-lowering drugs: true or random?

Br J Clin Pharmacol 2017 06 1;83(6):1197-1204. Epub 2017 Feb 1.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.13217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427237PMC
June 2017

The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy.

Diabetes Obes Metab 2017 05 22;19(5):749-753. Epub 2017 Feb 22.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12864DOI Listing
May 2017

Comparison of exposure response relationship of atrasentan between North American and Asian populations.

Diabetes Obes Metab 2017 04 27;19(4):545-552. Epub 2017 Jan 27.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12851DOI Listing
April 2017

Blood pressure-lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies.

Br J Clin Pharmacol 2016 11 18;82(5):1351-1357. Epub 2016 Aug 18.

Department of Internal Medicine, Division of Nephrology, University of Amsterdam, Academic Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.13062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061782PMC
November 2016

Determining the Optimal Protocol for Measuring an Albuminuria Class Transition in Clinical Trials in Diabetic Kidney Disease.

J Am Soc Nephrol 2016 Nov 7;27(11):3405-3412. Epub 2016 Apr 7.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2015101150DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084894PMC
November 2016

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

N Engl J Med 2016 11;375(18):1800-1

University Medical Center Groningen, Groningen, the Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1611290DOI Listing
November 2016

Prevalence and distribution of (micro)albuminuria in toddlers.

Nephrol Dial Transplant 2016 10 24;31(10):1686-92. Epub 2015 Dec 24.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://ndt.oxfordjournals.org/content/early/2015/12/23/ndt.g
Web Search
http://ndt.oxfordjournals.org/lookup/doi/10.1093/ndt/gfv407
Publisher Site
http://dx.doi.org/10.1093/ndt/gfv407DOI Listing
October 2016

Individual long-term albuminuria exposure during angiotensin receptor blocker therapy is the optimal predictor for renal outcome.

Nephrol Dial Transplant 2016 09 19;31(9):1471-7. Epub 2016 Jan 19.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfv429DOI Listing
September 2016

Unmet need in diabetic nephropathy: failed drugs or trials?

Lancet Diabetes Endocrinol 2016 08 6;4(8):638-640. Epub 2016 May 6.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(16)30045-6DOI Listing
August 2016

Novel anti-inflammatory drugs for the treatment of diabetic kidney disease.

Diabetologia 2016 08 23;59(8):1621-3. Epub 2016 Jun 23.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, PO Box 30001, 9700 RB, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-016-4030-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930464PMC
August 2016

Renal endothelial function is associated with the anti-proteinuric effect of ACE inhibition in 5/6 nephrectomized rats.

Am J Physiol Renal Physiol 2016 05 24;310(10):F1047-53. Epub 2016 Feb 24.

Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajprenal.00325.2015DOI Listing
May 2016

Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial.

Lancet Diabetes Endocrinol 2016 Apr 14;4(4):309-17. Epub 2016 Jan 14.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(15)00469-6DOI Listing
April 2016

Urine Albumin-Creatinine Ratio Versus Albumin Excretion for Albuminuria Staging: A Prospective Longitudinal Cohort Study.

Am J Kidney Dis 2016 Jan 15;67(1):70-8. Epub 2015 Jul 15.

Division of Nephrology, Department of Internal Medicine, Groningen, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2015.05.025DOI Listing
January 2016

The blood pressure lowering potential of sulodexide--a systematic review and meta-analysis.

Br J Clin Pharmacol 2015 Dec 24;80(6):1245-53. Epub 2015 Aug 24.

Division of Nephrology, Academic Medical Center, University of Amsterdam, Amsterdam.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.12722DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693497PMC
December 2015

The glycocalyx--linking albuminuria with renal and cardiovascular disease.

Nat Rev Nephrol 2015 Nov 13;11(11):667-76. Epub 2015 Oct 13.

Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Netherlands.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrneph.2015.162
Publisher Site
http://dx.doi.org/10.1038/nrneph.2015.162DOI Listing
November 2015

The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers.

Br J Clin Pharmacol 2015 Oct 28;80(4):678-86. Epub 2015 May 28.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.12655DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594704PMC
October 2015

Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetes.

J Hypertens 2015 Oct;33(10):2123-32

aDepartment of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands bUniversity Hospital RWTH, Institute for Molecular Cardiovascular Research, Aachen, Germany cCenter for Medical Statistics, Informatics, And Intelligent Systems, Medical University of Vienna, Vienna, Austria dDepartment of Nephrology, University of Erlangen-Nürnberg, Erlangen, Germany eemergentec biodevelopment GmbH, Vienna, Austria fDepartment of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands gSteno Diabetes Center, Gentofte hAarhus University, Aarhus iCenter for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000000685DOI Listing
October 2015

Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy.

Am J Nephrol 2014 17;40(1):64-74. Epub 2014 Jul 17.

The University of Chicago Medicine, Chicago, Ill., Janssen Research & Development, LLC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000364909DOI Listing
September 2015

Plasma 1,25-Dihydroxyvitamin D and the Risk of Developing Hypertension: The Prevention of Renal and Vascular End-Stage Disease Study.

Hypertension 2015 Sep 20;66(3):563-70. Epub 2015 Jul 20.

From the Department of Health Sciences and the EMGO Institute, VU University, Amsterdam, The Netherlands (A.J.v.B., M.V., I.A.B.); Department of Nephrology (R.T.G., M.H.d.B., S.J.L.B., M.M.J.), Department of Clinical Pharmacy and Pharmacology (H.J.L.-H., D.d.Z.), and Department of Clinical Chemistry (I.P.K.), University Medical Center Groningen, Groningen, The Netherlands; and Top Institute Food and Nutrition, Wageningen, The Netherlands (S.J.L.B., M.M.J.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.115.05837DOI Listing
September 2015

Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis.

J Am Soc Nephrol 2015 Aug 24;26(8):2055-64. Epub 2014 Nov 24.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2014070688DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520175PMC
August 2015

Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes.

Nephrol Dial Transplant 2015 Aug;30 Suppl 4:iv86-95

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfv252DOI Listing
August 2015

The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholders.

PLoS One 2014 30;9(9):e108722. Epub 2014 Sep 30.

Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0108722PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182561PMC
June 2015

Renal end points in clinical trials of kidney disease.

Curr Opin Nephrol Hypertens 2015 May;24(3):284-9

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNH.0000000000000118DOI Listing
May 2015

Number and frequency of albuminuria measurements in clinical trials in diabetic nephropathy.

Clin J Am Soc Nephrol 2015 Mar 7;10(3):410-6. Epub 2015 Jan 7.

Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.07780814DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348688PMC
March 2015

A novel approach for establishing cardiovascular drug efficacy.

Nat Rev Drug Discov 2014 12 14;13(12):942. Epub 2014 Nov 14.

Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrd4090-c2DOI Listing
December 2014

The authors reply.

Kidney Int 2014 Dec;86(6):1270

Division of Endocrinology, Metabolism and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ki.2014.263DOI Listing
December 2014

The validity of a patient-reported adverse drug event questionnaire using different recall periods.

Qual Life Res 2014 Nov 22;23(9):2439-45. Epub 2014 May 22.

Department of Clinical Pharmacy and Pharmacology (FB20), University of Groningen, University Medical Center Groningen, PO Box 196, 9700 AD, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11136-014-0715-7DOI Listing
November 2014

Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.

Am J Kidney Dis 2014 Nov 24;64(5):714-22. Epub 2014 Jul 24.

Department of Clinical Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2014.06.008DOI Listing
November 2014

Are post-trial observational studies useful?

J Am Soc Nephrol 2014 Oct 12;25(10):2148-50. Epub 2014 Jun 12.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2014040410DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178453PMC
October 2014

Do diabetic kidneys deserve a lifestyle change?

Lancet Diabetes Endocrinol 2014 Oct 10;2(10):769-70. Epub 2014 Aug 10.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, 9700 AD, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(14)70163-9DOI Listing
October 2014

Bilirubin and progression of nephropathy in type 2 diabetes: a post hoc analysis of RENAAL with independent replication in IDNT.

Diabetes 2014 Aug 27;63(8):2845-53. Epub 2014 Mar 27.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db13-1652DOI Listing
August 2014

Effects of lowering LDL cholesterol on progression of kidney disease.

J Am Soc Nephrol 2014 Aug 1;25(8):1825-33. Epub 2014 May 1.

Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2013090965DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116066PMC
August 2014

Microalbuminuria: target for renoprotective therapy PRO.

Kidney Int 2014 Jul 23;86(1):40-9. Epub 2014 Apr 23.

Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00852538153025
Publisher Site
http://dx.doi.org/10.1038/ki.2013.490DOI Listing
July 2014

Improving clinical trial efficiency by biomarker-guided patient selection.

Trials 2014 Apr 2;15:103. Epub 2014 Apr 2.

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1745-6215-15-103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229992PMC
April 2014